Publications by authors named "Eva Teschl"

Claim this Profile
A
Adenosine kinase (ADK) inhibition with ABT-702 induces ADK protein degradation and a distinct form of sustained cardioprotection.
Gerald Wölkart, Heike Stessel, Erin Fassett, Eva Teschl, Katrin Friedl

Eur J Pharmacol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis